Skip to search.
 TSX Down 0.61% TSX Ventures Up 0.04%

Novavax, Inc. (NVAX)

-NasdaqGS
9.00 Up 0.16(1.81%) 4:00PM EDT
|After Hours : 9.01 Up 0.01 (0.11%) 4:55PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:8.84
Open:8.82
Bid:8.85 x 500
Ask:9.01 x 200
1y Target Est:11.04
Beta:1.37
Earnings Date:Aug 4 - Aug 10 (Est.)
Day's Range:8.80 - 9.02
52wk Range:3.92 - 9.95
Volume:2,945,570
Avg Vol (3m):4,074,200
Market Cap:2.41B
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXUp 1.81%2.41B
MRKUp 1.99%172.03B
NVSDown 1.46%248.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):71.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.42
Quarterly EPS Est (Jun-15) :-0.09
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback